SCHEMBL6051820

SCHEMBL6051820

O=C(O)c1cccc(C2=CCCC2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACMSD Q8TDX5 2/20 0.56
▸ SERPINE1 P05121 1/20 0.54
▸ KMO O15229 2/20 0.53
▸ RXRA P19793 2/20 0.47
▸ RXRB P28702 2/20 0.47
▸ PDE4A P27815 1/20 0.46
▸ PDE4B Q07343 1/20 0.46
▸ PDE4C Q08493 1/20 0.46
▸ PDE4D Q08499 1/20 0.46
▸ KEAP1 Q14145 1/20 0.45
▸ FOLH1 Q04609 1/20 0.45
▸ CD74 P04233 1/20 0.43
▸ MIF P14174 1/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ CA6 P23280 1/20 0.43
▸ CA9 Q16790 1/20 0.43
▸ GAA P10253 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31554955 0.95 SERPINE1 (0.59) ACMSDSERPINE1KMORXRARXRB
SCHEMBL417671 0.95 SERPINE1 (0.59) ACMSDSERPINE1KMORXRARXRB
SCHEMBL27853805 0.82 SERPINE1 (0.51) ACMSDSERPINE1KMORXRARXRB
SCHEMBL11675977 0.81 SERPINE1 (0.52) ACMSDSERPINE1ALDH1A1LMNA
SCHEMBL3751478 0.80 ACMSD (0.60) ACMSDRXRARXRBPDE4APDE4B
SCHEMBL31705648 0.76 FABP7 (0.53) KMORXRARXRBKEAP1FOLH1
SCHEMBL13406396 0.76 SIGMAR1 (0.62) KMO
SCHEMBL3107969 0.76 FABP7 (0.53) KMORXRARXRBKEAP1FOLH1
SCHEMBL2724549 0.75 ACMSD (0.48) ACMSDSERPINE1KDM4EMEN1ALDH1A1
SCHEMBL30725957 0.75 KMO (0.86) KMORXRARXRBKEAP1CD74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1551821-B1 3-(CYCLOPENTEN-1-YL)-BENZYL- OR 3-(CYCLOPENTEN-1-YL)-HETEROARYLMETHYL-AMINE DERIVATIVES AND USE THEREOF AS MEDICINES FOR TREATING SCHIZOPHRENIA PF MEDICAMENT (FR) 2006-05-17 — — EP disclosed
EP-1551821-A1 3-(CYCLOPENTEN-1-YL)-BENZYL- OR 3-(CYCLOPENTEN-1-YL)-HETEROARYLMETHYL-AMINE DERIVATIVES AND USE THEREOF AS MEDICINES FOR TREATING SCHIZOPHRENIA PIERRE FABRE MEDICAMENT (FR) 2005-07-13 — — EP disclosed
WO-2004035561-A1 3-(CYCLOPENTEN-1-YL)-BENZYL- OR 3-(CYCLOPENTEN-1-YL)-HETEROARYLMETHYL-AMINE DERIVATIVES AND USE THEREOF AS MEDICINES FOR TREATING SCHIZOPHRENIA PIERRE FABRE MEDICAMENT (FR) 2004-04-29 — — WO disclosed
US-6313365-B1 Ruthenium metathesis catalyst and method for producing olefin reaction product by metathesis reaction using the same TAKASAGO INTERNATIONAL CORPORATION (JP) 2001-11-06 — — US disclosed
US-6175047-B1 A CATALYST MIXTURE INCLUDING A RUTHENIUM COMPOUND, A DIHALOGENO COMPOUND, A TERMINAL ALKYNE; AS A CATALYST FOR A CARBON-CARBON BOND FORMATION REACTION TAKASAGO INTERNATIONAL CORPORATION (JP) 2001-01-16 — — US disclosed
EP-0927577-A1 Ruthenium metathesis catalyst and method for producing olefin reaction product by metathesis reaction using the same Takasago International Corporation (JP) 1999-07-07 — — EP disclosed
Send feedback